×
Halperin Wernli was appointed Executive President in February 2021 and has served on our Board of Directors since August 2020. Prior to joining MindMed, Dr. Halperin Wernli co-founded Creso Pharma, a medical cannabis company, and listed the company on the Australian Stock exchange (ASX) in October 2016.
MindMed is a clinical stage biopharmaceutical company developing novel product candidates…
Miri Halperin Wernli daripada www.businessnews.com.au
Dr Miri Halperin Wernli is a senior pharmaceutical and biomedical executive with over 25 years of strategic and operational leadership in the biopharm.
Miri Halperin Wernli is the founder of Melodiol Global Health Ltd., which was founded in 2015. She held the title of Group CEO, Managing Director ...
Miri Halperin Wernli daripada theorg.com
Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership in the biopharmaceutical ...
Miri Halperin Wernli is the director & Executive President of Mind Medicine Inc. Other key executives at Mind Medicine Inc include Chief Legal Officer Mark ...
Miri Halperin Wernli is Executive President at MindMed. She attended Stanford Graduate School of Business.
15 Jun 2023 · Miri Halperin Wernli's Post · The Psychedelic Scientist Who Sends Brains Back to Childhood · More Relevant Posts · F.D.A.'s Review of MDMA Cites ...
Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership in the biopharmaceutical ...